miR-221/miR-222与肿瘤

被引：2
|
作者：
廖立
奉水东
机构：
[1] 南华大学公共卫生学院
来源：
中国癌症防治杂志 | 2014年 / 6卷 / 04期
关键词：
肿瘤; miR-221/mi R-222; 生物标志物;
D O I：
暂无
中图分类号：
R730.2 [肿瘤病理学、病因学];
学科分类号：
摘要：
肿瘤的发生是一个多因素参与的阶段性演进过程,研究发现miR-221/mi R-222在多数肿瘤中的表达失调,通过负调控抑癌基因或癌基因的表达,促进或抑制肿瘤的发生、发展。现就miR-221/miR-222在肿瘤中的表达、作用及其临床意义作一综述,并探讨miR-221/miR-222在肿瘤治疗中的潜在价值。
引用
收藏
页码：408 / 411
页数：4
相关论文
共 10 条
  • [1] miR-221/222 Confers Radioresistance in Glioblastoma Cells Through Activating Akt Independent of PTEN Status
    Li, W.
    Guo, F.
    Wang, P.
    Hong, S.
    Zhang, C.
    [J]. CURRENT MOLECULAR MEDICINE, 2014, 14 (01) : 185 - 195
  • [2] miR-221/222 control luminal breast cancer tumor progression by regulating different targets
    Dentelli, Patrizia
    Traversa, Matteo
    Rosso, Arturo
    Togliatto, Gabriele
    Olgasi, Cristina
    Marchio, Caterina
    Provero, Paolo
    Lembo, Antonio
    Bon, Giulia
    Annaratone, Laura
    Sapino, Anna
    Falcioni, Rita
    Brizzi, Maria Felice
    [J]. CELL CYCLE, 2014, 13 (11) : 1811 - 1826
  • [3] Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients
    Teixeira, Ana L.
    Ferreira, Marta
    Silva, Joana
    Gomes, Monica
    Dias, Francisca
    Santos, Juliana I.
    Mauricio, Joaquina
    Lobo, Francisco
    Medeiros, Rui
    [J]. TUMOR BIOLOGY, 2014, 35 (05) : 4057 - 4066
  • [4] The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway
    Errico, M. Cristina
    Felicetti, Federica
    Bottero, Lisabianca
    Mattia, Gianfranco
    Boe, Alessandra
    Felli, Nadia
    Petrini, Marina
    Bellenghi, Maria
    Pandha, Hardev S.
    Calvaruso, Marco
    Tripodo, Claudio
    Colombo, Mario P.
    Morgan, Richard
    Care, Alessandra
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (04) : 879 - 892
  • [5] Downregulation of miR-221/222 sensitizes glioma cells to temozolomide by regulating apoptosis independently of p53 status
    Chen, Lingchao
    Zhang, Junxia
    Han, Lei
    Zhang, Anling
    Zhang, Chunzhi
    Zheng, Yongri
    Jiang, Tao
    Pu, Peiyu
    Jiang, Chuanlu
    Kang, Chunsheng
    [J]. ONCOLOGY REPORTS, 2012, 27 (03) : 854 - 860
  • [6] Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance[J] . Andreas Karakatsanis,Ioannis Papaconstantinou,Maria Gazouli,Anna Lyberopoulou,George Polymeneas,Dionysios Voros. Mol. Carcinog. . 2011 (4)
  • [7] Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance
    Li, Jipeng
    Wang, Yiping
    Yu, Wanjun
    Chen, Jun
    Luo, Jianping
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 406 (01) : 70 - 73
  • [8] Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors
    Koelz, Marita
    Lense, Josefine
    Wrba, Fritz
    Scheffler, Melanie
    Dienes, Hans Peter
    Odenthal, Margarete
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 38 (02) : 503 - 511
  • [9] miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation[J] . Michela Garofalo,Gianpiero Di Leva,Giulia Romano,Gerard Nuovo,Sung-Suk Suh,Apollinaire Ngankeu,Cristian Taccioli,Flavia Pichiorri,Hansjuerg Alder,Paola Secchiero,Pierluigi Gasparini,Arianna Gonelli,Stefan Costinean,Mario Acunzo,Gerolama Condorelli,Carlo Maria Croce. Cancer Cell . 2009 (6)
  • [10] MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer .2 Zhao Jian-Jun,Lin Jianhong,Yang Hua,Kong William,He Lili,Ma Xu,Coppola Domenico,Cheng Jin Q. The Journal of biological chemistry . 2008
1